91results about How to "Control bleeding" patented technology

A set of printing liquids is disclosed comprising a first anionic printing liquid comprising an aqueous vehicle, at least one first colorant, and at least one first anionic polymer; a second anionic printing liquid comprising an aqueous vehicle at least one second colorant, at least one second anionic polymer, and an acid additive having a pKa up to the pKa of the at least first polymer of the first liquid; a third cationic printing liquid comprising an aqueous vehicle, at least one third colorant, at least one third cationic polymer, and a pH in the range from about 2 to about 5; and a fourth anionic printing liquid comprising an aqueous vehicle, at least one fourth anionic dye, and a precipitating agent. More specifically, the present set of printing liquids may find application in ink-jet printing. The set of ink-jet inks provides improved print quality, specifically, reduced bleed; improved edge-acuity, uniform area fills, and color quality; while maximizing lightfastness without sacrificing printing reliability.

Compositions that include nanoscale structured materials or precursors thereof (e.g., self-assembling peptides) are described. The compositions can include other substances (e.g., a vasoconstrictor). Also described are methods for using the compositions to promote hemostasis, to protect the skin or wounds from contamination, to decontaminate a site upon removal of previously applied compositions that provided a protective coating, and to inhibit the movement of bodily substances other than blood. The compositions are also useful in isolating tissue, removing tissue, preserving tissue (for, e.g., subsequent transplantation or reattachment), and as bulking, stabilizing or hydrating agents. Medical devices that include the compositions (e.g., a stent or catheter), bandages or other wound dressings, sutures, and kits that include the compositions are also described.

A hemostatic article, e.g., a sponge is pretreated with predetermined quantities of selected hemostatic agents to assist hemostasis in surgical or traumatic wounds. The hemostatic article is provided with a visible marking/indication of the strength of the hemostatic agent. The visible indication may be color coding, or, the marking could take the form 20%, 40%, 60% and, 80%. The hemostatic agent may be any substance assisting in hemostasis, may be in powder or fluid form, and may be one or more of Thrombin, Gelform, Fibrinogen, or other hemostatic substances. The hemostatic article could include at least one radio-opaque element which may take the form of a thread or a strip. Alternatively, a radio chip embedded in the hemostatic article may be used. The visible markings per se could be made radio-opaque, thereby obviating a separate radio-opaque element. The pretreated marked hemostatic articles are sterilized for medical use in any known manner.

An apparatus and method of use or treatment are disclosed for creating intrauterine adhesions resulting in amenorrhea. In particular, the apparatus relates to an easily deployed intrauterine implant that readily and consistently reduces or eliminates abnormal intrauterine bleeding. In addition, the apparatus is also used as a uterine marker device for visualizing endometrial tissue thickness and potential changes. The method of the present invention serves as a supplement to or a replacement for conventional hysterectomy or ablation/resection procedures used to treat menorrhagia.

A method of treatment of ocular compartment syndromes is provided. Known ocular compartment syndromes include central retinal vein occlusion (CRVO), branch retinal vein occlusion (BRVO), non-arteritic anterior ischemic optic neuropathy (NAAION), and papilledema. One or more lasers known to have photoablative, photodisruptive, or photocoagulative effects are used to decompress the ocular compartment syndromes. The method includes the steps of positioning a patient beneath an operative microscope (110) and one or more lasers (108,109,111), positioning a fixation ring (104) on the operative eye (102) identifying the site of the occlusion using an operative microscope (110), and directing laser energy at the target tissue responsible for the occlusion. A display (112) is provided to guide the surgeon performing the laser treatments. A microscope and laser control system (114) is provided to allow the surgeon to control the operative microscope (110) and the lasers (108,109,111).

Devices that are adapted to insert a sinus dilator into a stenotic opening of a paranasal sinus in a subject patient using minimally invasive insertion procedures are provided. The devices and methods can be used to treat sinusitis and other nasal and/or sinus disorders.

This is directed to methods and devices suited for airway based measurements of pressure in a pulmonary artery. A device is advanced into an airway and in the vicinity of the pulmonary artery. Physical properties of the pulmonary artery are observed through the airway wall using one or more minimally invasive modalities. In a variation, a bronchial balloon catheter measures pressure of the pulmonary artery.

An ink-jet printing system is disclosed comprising a set of ink-jet inks comprising a first anionic ink comprising an aqueous vehicle, at least one first colorant, and at least one first anionic polymer; a second anionic ink comprising an aqueous vehicle; at least one second colorant, at least one second anionic polymer, and an acid additive having a pKa up to the pKa of the at least first polymer of the first ink; a third cationic ink comprising an aqueous vehicle, at least one third colorant, at least one third cationic polymer, and a pH in the range from about 2 to about 5; and a fourth anionic ink comprising an aqueous vehicle, at least one fourth anionic dye, and a precipitating agent. The printing system provides improved print quality, specifically, reduced bleed; improved edge-acuity, uniform area fills, and color quality; while maximizing lightfastness without sacrificing printing reliability.

An emergency helmet trauma bandage and method of use, which, when applied, applies minimal pressure to stop bleeding, doesn't compromise cervical spine immobilization, allows for fast and effective application of ice/cold packs to control intracranial/internal swelling, doesn't come apart during treatment and transport, and doesn't require a caregiver to re-wrap the dressing.

A medical device and method for treating nose bleeds are provided. The device includes packing material interconnected to a flange member. The packing material is insertable into a nasal cavity, for absorbing blood and other body fluids. The flange member prevents the packing material from being inhaled or otherwise moving in an anterior direction. In addition, the flange member obscures a view of the interior of the user's nasal cavity, and therefore of blood within the cavity, or of blood that has been absorbed by the packing member.

The present invention relates to a proteinaceous construct comprising plasmatic or recombinant factor VIIa (FVIIa) or biologically active derivatives thereof, which are bound to a carbohydrate moiety comprising 1-4 sialic acid units, wherein the in vivo half-life of the proteinaceous construct is substantially prolonged in the blood of a mammal, as compared to the in vivo half-life of a FVIIa molecule not bound to a carbohydrate moiety. The invention also provides a method for controlling bleeding in a mammal having a bleeding disorder due to functional defects or deficiencies of FVIIa, FVIII, or FIX. The invention also provides a method for controlling bleeding in a mammal during surgery or trauma.

The invention features methods and devices for controlling bleeding from blood vessels that may be damaged as a result of trauma or impact with an object, such as a bullet or shrapnel. The device may be wearable by a user and include one or more components, such as wound sealant and multiple inflatable balloons/bladders. The device may be integrated into a garment, e.g., a vest, jacket, trousers, or full body suit. Once triggered (automatically or manually), the device may be used to deliver wound sealant to a wound site and/or pressure to the wound site by selective inflation of one or more balloons over exsanguinating blood vessels that may be damaged, thereby stopping or minimizing the bleeding. Alternatively, or in addition, the device may be used to stabilize a wounded wearer for, e.g., transportation purposes, or to provide buoyancy. Devices of the invention may also be used as a blood pressure monitor, as a massaging device, and as a breast pump. Devices and methods of the invention may also be used for repairing or stabilizing machines, such as vehicles (e.g., automobiles and boats).

The invention describes families of compounds that utilize multihydroxyl phenyl groups to provide adhesive properties. Selection of the multihydroxy phenyl group along with linkers or linking groups and the linkages between the linkers or linking groups with polyalkylene oxides, provides materials that can be engineered to afford controllable curing time, biodegradation and/or swelling.

An emergency head trauma bandage cap with a detachable strap system and method of use, which, when applied to the head, delivers minimal pressure to control bleeding, doesn't compromise cervical spine immobilization, allows for fast and effective application of cold packs to control intracranial/internal swelling or hot packs to prevent hypothermia in non-trauma situations, doesn't come apart during treatment and transport, and doesn't require a caregiver to re-wrap the dressing.

A pair of tongs are joined together by a pivot wherein one end of each of the respective tongs includes a handle portion and a spring biasing mechanism which expands against the respective handle portions so that the opposite end of the tongs carrying cantilevered prongs are normally biased together. The prongs curve at a 90° angle and extend outwardly from the instrument at the distal end in curvatures. A selected one of the prongs is provided with an elongated slot for mounting of a suction tube. One end of the suction tube terminates adjacent the curved tip while the opposite end of the suction tube is connected to a source of suction.

A multifunctional anti-cracking water-proofing agent for improving the flowability and slump of concrete, increasing the strength, impervious performance and compactness of solidified concrete, and decreasing the consumption of water is prepared proportionally from high-concentration naphthelene-series efficient water reducing agent, sodium laurylsulfate, sodium gluconate, hydroxypropyl methylcellulose, vinyl acetate-ethene copolymer emulsion and water through sequential mixing and stirring.

The present invention provides methods and compositions for treating blood clotting factor disorders and/or reducing bleeding-associated joint damage by treatments delivered to the joint in a subject.

The invention discloses a compression hemostat applied to esophagus and fundus ventriculi. The compression hemostat comprises a stent which can expand and is provided with a channel in the middle, and a bleeding arresting dressing fixed on the outer side of the stent. When massive hemorrhage caused by varicose veins of esophagus and fundus ventriculi occurs, the compression hemostat is placed at a bleeding position by using a stent inserter for arresting bleeding, and the bleeding arresting dressing is closely contacted with the bleeding position under the compression action of the expanding stent, so that the aim of arresting bleeding is fulfilled. The invention has the beneficial effects that: the compression hemostat is easy to operate and is convenient to use, and massive hemorrhage of esophagus and fundus ventriculi can be controlled effectively.